CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2015 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
CSBR on Nasdaq
Shares outstanding
13,838,977
Price per share
$6.91
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
5,750,673
Total reported value
$39,735,823
% of total 13F portfolios
0%
Share change
+87,616
Value change
+$624,113
Number of holders
26
Price from insider filings
$6.91
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TOCQUEVILLE ASSET MANAGEMENT L.P. 4.4% $4,633,843 608,915 Tocqueville Asset Management L.P. 31 Dec 2024

As of 31 Dec 2025, 26 institutional investors reported holding 5,750,673 shares of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR). This represents 42% of the company’s total 13,838,977 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) together control 42% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BATTERY MANAGEMENT CORP. 17% 2,421,673 0% 2.7% $16,733,760
NEA Management Company, LLC 12% 1,713,720 0% 0.6% $11,841,805
VANGUARD GROUP INC 2.4% 334,605 +0.4% 0% $2,312,121
TOCQUEVILLE ASSET MANAGEMENT L.P. 2.3% 319,674 0% 0.03% $2,208,947
MORGAN STANLEY 1.7% 229,659 +21% 0% $1,586,944
RENAISSANCE TECHNOLOGIES LLC 1.1% 154,839 -7.4% 0% $1,069,937
BlackRock, Inc. 0.89% 122,771 +0.71% 0% $848,348
Mink Brook Asset Management LLC 0.58% 80,305 0.35% $554,908
GEODE CAPITAL MANAGEMENT, LLC 0.55% 75,819 +1.9% 0% $524,019
NORTHERN TRUST CORP 0.33% 46,146 -0.62% 0% $318,869
HighTower Advisors, LLC 0.25% 35,158 0% 0% $242,942
ACADIAN ASSET MANAGEMENT LLC 0.22% 29,995 -17% 0% $206,000
Bank of New York Mellon Corp 0.19% 26,749 0% 0% $184,836
STATE STREET CORP 0.19% 26,203 0% 0% $181,063
DIMENSIONAL FUND ADVISORS LP 0.18% 25,354 +7% 0% $174,882
BANK OF AMERICA CORP /DE/ 0.16% 21,985 +0.96% 0% $151,916
GSA CAPITAL PARTNERS LLP 0.15% 20,978 +101% 0.01% $145,000
ESSEX INVESTMENT MANAGEMENT CO LLC 0.13% 18,249 0.02% $126,101
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 0.09% 13,031 -9.9% 0% $90,044
Cambridge Investment Research Advisors, Inc. 0.09% 12,252 0% 0% $85,000
Mesirow Financial Investment Management, Inc. 0.07% 10,300 -14% 0% $71,173
MILLENNIUM MANAGEMENT LLC 0.07% 10,203 -19% 0% $70,503
WHITTIER TRUST CO 0.01% 800 0% 0% $5,288
UBS Group AG 0% 190 0% $1,313
JPMORGAN CHASE & CO 0% 11 0% 0% $76

Institutional Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 5,750,673 $39,735,823 +$624,113 $6.91 26
2025 Q3 5,663,057 $36,665,391 -$761,415 $6.48 26
2025 Q2 5,772,731 $42,541,525 -$1,253,103 $7.37 29
2025 Q1 5,917,321 $51,360,014 +$1,723,264 $8.68 33
2024 Q4 5,718,824 $49,008,702 -$371,113 $8.57 24
2024 Q3 5,783,612 $28,164,672 +$38,335 $4.87 21
2024 Q2 5,774,158 $29,850,843 +$747,882 $5.17 23
2024 Q1 5,633,547 $27,601,085 +$42,514 $4.90 24
2023 Q4 5,612,282 $31,482,391 -$753,086 $5.62 23
2023 Q3 5,738,643 $35,637,624 -$450,468 $6.21 28
2023 Q2 5,810,614 $37,033,240 -$275,967 $6.38 27
2023 Q1 5,860,555 $23,555,996 -$669,606 $4.02 29
2022 Q4 6,003,532 $27,075,368 -$820,131 $4.51 27
2022 Q3 6,237,577 $46,781,000 -$101,195 $7.50 27
2022 Q2 6,220,826 $49,800,000 +$418,571 $8.00 27
2022 Q1 6,195,380 $50,369,000 -$90,258 $8.13 27
2021 Q4 6,206,609 $51,745,000 -$921,951 $8.35 29
2021 Q3 6,278,256 $64,114,459 -$3,861,348 $10.21 33
2021 Q2 6,655,344 $68,450,153 -$6,271,556 $10.28 36
2021 Q1 7,201,194 $81,382,735 +$856,252 $11.30 44
2020 Q4 7,131,440 $76,929,434 +$1,001,410 $10.79 46
2020 Q3 7,084,905 $65,541,431 +$877,249 $9.25 45
2020 Q2 6,969,631 $66,613,581 +$4,981,325 $9.56 45
2020 Q1 6,466,834 $47,788,000 +$5,396,239 $7.40 28
2019 Q4 5,735,595 $47,777,000 +$635,595 $8.33 28
2019 Q3 5,731,540 $32,382,000 -$1,578,376 $5.65 30
2019 Q2 5,967,794 $46,727,000 -$1,774,036 $7.83 35
2019 Q1 6,135,684 $60,069,000 +$1,291,252 $9.79 37
2018 Q4 6,039,426 $47,166,000 +$436,336 $7.81 45
2018 Q3 5,687,065 $99,351,000 +$24,496,352 $17.47 35
2018 Q2 4,298,835 $27,271,000 +$1,162,771 $6.34 18
2018 Q1 4,281,229 $15,580,000 +$423,759 $3.64 13
2017 Q4 4,163,006 $16,152,000 +$16,848 $3.88 13
2017 Q3 4,176,790 $15,334,000 +$98,739 $3.68 16
2017 Q2 4,172,600 $10,725,000 +$85,867 $2.57 15
2017 Q1 4,138,713 $13,118,000 -$538,128 $3.17 15
2016 Q4 4,321,802 $10,933,000 -$1,579,267 $2.53 10
2016 Q3 5,129,977 $8,615,000 -$407,141 $1.68 17
2016 Q2 5,370,595 $11,545,000 +$491,701 $2.15 12
2016 Q1 5,141,655 $18,718,000 +$7,584 $3.64 9
2015 Q4 5,139,584 $18,348,000 +$861,852 $3.57 12
2015 Q3 4,897,826 $26,188,000 +$26,187,984 $5.35 9